Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00459732 · ClinicalTrials.gov registry record · NA
Zinc & Bone Health in Thalassemia: The Think Zinc Study
A NA study, sponsored by UCSF Benioff Children's Hospital Oakland.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT00459732: Completed NA study, sponsored by UCSF Benioff Children's Hospital Oakland.
NCT00459732 is a NA study that has completed, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00459732, a NA study, has completed, sponsored by UCSF Benioff Children's Hospital Oakland.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether zinc can improve bone health in young patients with thalassemia.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Zinc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2006-04 |
| Est. Completion | 2011-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00459732
The ClinicalTrials.gov registry entry for NCT00459732 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UCSF Benioff Children's Hospital Oakland, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00459732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00459732 about?
NCT00459732 is a clinical study titled "Zinc & Bone Health in Thalassemia: The Think Zinc Study". The purpose of this study is to test whether zinc can improve bone health in young patients with thalassemia.
What is the current status of trial NCT00459732?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2006-04. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00459732?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Zinc (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00459732?
This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.